Application of the adult International Germ Cell Classification System to pediatric malignant non‐seminomatous germ cell tumors: A report from the Children's Oncology Group
- 19 December 2007
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 50 (4) , 746-751
Abstract
Background: The purpose of this analysis is to explore whether the International Germ Cell Classification Consensus (IGCCC) tumor marker criteria, developed for adult males with metastatic malignant germ cell tumors (MGCT), are prognostic among pediatric patients and whether tumor marker data may be relevant in pediatric risk stratification.Procedure: The IGCCC was applied to 436 pediatric germ cell patients treated on Pediatric Intergroup Studies from 1990 to 1996. Multivariable Cox proportional hazards model identified prognostic variables; survival rates among IGCCC risk groups were compared using the log‐rank test. Concordance and relative performance of IGCCC versus COG risk stratification was evaluated.Results: Applying the IGCCC, 21% of pediatric patients were good risk (GR), 35% intermediate risk (IR), and 44% poor risk (PR). Only modest concordance between IGCCC and COG stratification systems was noted (49%). Nonetheless, the IGCCC identified a group of PR patients who had significantly worse event‐free survival (EFS) versus GR/IR patients (6‐year EFS 80% vs. 91%), which was similar to the difference observed using the COG system (6‐year EFS 77% vs. 90%). The IGCCC performed well within subgroups for which the IGCCC is not intended (prepubertal, female, and non‐metastatic patients).Conclusions: Applying the IGCCC system to pediatric patients produces a different stratification than does the application of the COG system, although both are prognostic. Development of a de novo pediatric prognostic classification is warranted. Pediatr Blood Cancer 2008;50:746–751.Keywords
Funding Information
- NIH/NCI (U10-CA29139, U10-CA98413-02)
This publication has 15 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Prognostic Factors in Children With Extragonadal Malignant Germ Cell Tumors: A Pediatric Intergroup StudyJournal of Clinical Oncology, 2006
- Treatment of Children and Adolescents With Stage II Testicular and Stages I and II Ovarian Malignant Germ Cell Tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children's Cancer Group 8891Journal of Clinical Oncology, 2004
- Randomized Comparison of Combination Chemotherapy With Etoposide, Bleomycin, and Either High-Dose or Standard-Dose Cisplatin in Children and Adolescents With High-Risk Malignant Germ Cell Tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9049 and Children's Cancer Group 8882Journal of Clinical Oncology, 2004
- Prognostic Value of Tumor Size, Metastases, Extension into Bone, and Increased Tumor Marker in Children With Malignant Sacrococcygeal Germ Cell Tumors: A Prospective Evaluation of 71 Patients Treated in the German Cooperative Protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89Journal of Clinical Oncology, 2003
- Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.2001
- Prognostic Factors in Children With Localized Malignant Nonseminomatous Germ Cell TumorsJournal of Clinical Oncology, 1999
- Serum Alpha Fetoprotein (AFP) Levels in Normal InfantsPediatric Research, 1981
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958